NASDAQ:ORKA Healthcare · FY 2025-12-31

Oruka Therapeutics, Inc.

0.025.350.575.8101.0ABVfair 9.63buy ≤ 2.41EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 93.55 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
93.550 USD
Market cap
4.56B USD
P / B
9.72
P / E
EPS
-1.850
DPS / yield
(0.0%)
NAV / share
9.626
Graham number
Z'' score
26.80
Piotroski F
1 / 9
Beneish M
ROIC vs WACC
-22.6% vs 11.0%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

1 Create your account

Free, takes about a minute.

Create free account
2 Subscribe to Pro

C$29 Monthly C$290 Annual

Available from your account once you're signed in.

Already have an account? Log in.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

1 Create your account

Free, takes about a minute.

Create free account
2 Subscribe to Pro

C$29 Monthly C$290 Annual

Available from your account once you're signed in.

Already have an account? Log in.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

1 Create your account

Free, takes about a minute.

Create free account
2 Subscribe to Pro

C$29 Monthly C$290 Annual

Available from your account once you're signed in.

Already have an account? Log in.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

1 Create your account

Free, takes about a minute.

Create free account
2 Subscribe to Pro

C$29 Monthly C$290 Annual

Available from your account once you're signed in.

Already have an account? Log in.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

1 Create your account

Free, takes about a minute.

Create free account
2 Subscribe to Pro

C$29 Monthly C$290 Annual

Available from your account once you're signed in.

Already have an account? Log in.